Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer
Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer
Brothers Of Prostate Cancer Patients At Risk Of Diagnosis
Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI
Tumors Harder To Detect In Women In Their Forties
Two Avastin Trials Show OS Benefit In Advanced Disease
Risk-Benefit Analysis Advised Prior To Hormone Therapy
Elderly Patients Fail To Receive New Cancer Therapy For CML
Rising Obesity May Result In Higher Cancer Incidence
Study Finds Relationship Between Meat Intake, Cancer
Radiation To Stem Cell Niche Improved PFS In Glioblastoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- House passes Mikaela Naylon Give Kids a Chance Act—next step, the Senate
- Should I have a drink tonight?
In anticipation of the first holiday season since the surgeon general’s report on alcohol and cancer, we ask experts to weigh in - Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Testing for asbestos in talc-based cosmetics seems like a no-brainer—why did FDA withdraw a rule to standardize it?
- The Cancer Letter’s most-read stories of 2025
As MAHA-led policies took hold, oncology navigated through uncertainty and turmoil
